Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
Primary Purpose
Cancer of Breast, Cancer Colon
Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
ONS Pre-op + ONS Post-op
ONS Pre-op + ONS Post-op + ONS Post-op 3 months
Usual intake Pre-op + ONS Post-op
Sponsored by

About this trial
This is an interventional supportive care trial for Cancer of Breast
Eligibility Criteria
Inclusion Criteria:
- Male or female from all ethnicity
- 25 to 65 years
- BMI not less than 18.0 kg/m²
- Cancer patients who are confirmed with elective surgery whose co-morbidities are stabilized based on the ASA Physical Status Classification System ASA Class 1 and 2
- Fulfil at least two characteristics of AND/ ASPEN Diagnosis of Malnutrition These characteristics are insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, localized or generalized fluid accumulation and diminished functional status as measured by handgrip strength.
Exclusion Criteria:
- Patients who require enteral or parenteral feeding
- Pregnant or lactating
- On chemotherapy or radiotherapy
- Total gastrectomy or ileostomy
- Metastasized cancer, upper gastrointestinal cancer, terminal diseases, decompensated liver or renal disease, major concurrent metabolic problem such as uncontrolled diabetes, dementia
- On regular steroids prescription
Sites / Locations
- International Medical University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
ONS Pre-op + ONS Post-op
ONS Pre-op + ONS Post-op + ONS Post-op 3 months
Usual intake Pre-op + ONS Post-op
Arm Description
Oral nutrition supplementation (ONS) pre-operatively and post-operatively up to being discharged from hospital
Oral nutrition supplementation (ONS) pre-operatively, post-operatively up to being discharged from hospital and an extended oral nutrition supplementation post-operatively up to 3 months
Follow a meal plan of 2000 kcal / day using conventional foods and oral nutrition supplementation (ONS) post-operatively up to being discharged from hospital
Outcomes
Primary Outcome Measures
Change in body weight
Anthropometry measurement
Change in body mass index (BMI)
Anthropometry measurement
Change in serum albumin level
Serum albumin is an indicator of protein stores to assess nutritional status
Change in serum pre-albumin level
Serum pre-albumin is an indicator of protein stores to assess nutritional status
Secondary Outcome Measures
Change in handgrip force
Handgrip force is a measure of handgrip strength by dynamometer
Change in muscle mass
Muscle mass reported in kilogram is measured by bioelectrical impedance analyser
Change in fat mass
Fat mass reported in kilogram is measured by bioelectrical impedance analyser
Change in serum transferrin level
Serum transferrin is a measure of nutritional status
Change in hemoglobin level
Serum hemoglobin is a measure of nutritional status
Change in high sensitivity c-reactive protein (HsCRP) level
High sensitivity c-reactive protein (HsCRP) is a measure of inflammatory status
Change in Interleukin-6 (IL-6)
Interleukin-6 (IL-6) is a measure of inflammatory status
Change in salivary cortisol level
Salivary cortisol level is a biological marker of stress reaction
Change in energy intake
Energy intake reported in calories is a dietary measure to assess nutritional status
Change in protein intake
Protein intake reported in gram is a dietary measure to assess nutritional status
Change in Pittsburgh Sleep Quality Index (PSQI) scores
Pittsburgh Sleep Quality Index (PSQI) scores range from 0-42.Higher scores indicate poorer sleep quality
Presence of post-surgical complications
Post-surgical complications are indicated by presence of wound infection, chest infection and use of antibiotics, responses are either yes or no
Length of hospital stay
Number of days participants are admitted into the hospital
Full Information
NCT ID
NCT04400552
First Posted
April 28, 2020
Last Updated
August 23, 2021
Sponsor
International Medical University
Collaborators
Kotra Pharma (M) Sdn Bhd
1. Study Identification
Unique Protocol Identification Number
NCT04400552
Brief Title
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
Official Title
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients- A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
December 26, 2018 (Actual)
Primary Completion Date
June 30, 2021 (Actual)
Study Completion Date
June 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
International Medical University
Collaborators
Kotra Pharma (M) Sdn Bhd
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the effectiveness of perioperative oral nutrition supplementation (ONS) on nutritional status in malnourished cancer patients undergoing elective surgery.
The hypothesis is pre-operative ONS feeding in malnourished surgical cancer patients is effective on improving nutritional status. An extended period of 3 months post-operative ONS feeding is effective on improving nutritional status as compared to ONS feeding post-operatively during hospital stay only. Perioperative feeding is effective on improving secondary outcomes such as sleep quality, post-operative complications and length of hospital stay.
Detailed Description
The main objective of this study is to evaluate the effectiveness of perioperative oral nutrition supplementation (ONS) on nutritional status in malnourished cancer patients undergoing elective surgery.
The specific objectives are:
To evaluate the baseline nutritional status of cancer patients undergoing elective surgery
To evaluate the effectiveness of pre-operative ONS feeding on nutritional status in malnourished surgical cancer patients
To evaluate the effectiveness of an extended 3 months post-operative ONS feeding after discharge versus ONS feeding only post-operatively during hospital on nutritional status
To evaluate secondary outcomes of perioperative feeding such as sleep quality, post-operative complications and length of hospital stay
Study Design: This is a randomised-controlled-open label-parallel group(s)-trial which will be conducted on malnourished cancer patients undergoing elective surgery.
Study duration: The participation duration for each participant is 4 months. The completion of the study will take around 30 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer of Breast, Cancer Colon
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
91 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ONS Pre-op + ONS Post-op
Arm Type
Active Comparator
Arm Description
Oral nutrition supplementation (ONS) pre-operatively and post-operatively up to being discharged from hospital
Arm Title
ONS Pre-op + ONS Post-op + ONS Post-op 3 months
Arm Type
Active Comparator
Arm Description
Oral nutrition supplementation (ONS) pre-operatively, post-operatively up to being discharged from hospital and an extended oral nutrition supplementation post-operatively up to 3 months
Arm Title
Usual intake Pre-op + ONS Post-op
Arm Type
Active Comparator
Arm Description
Follow a meal plan of 2000 kcal / day using conventional foods and oral nutrition supplementation (ONS) post-operatively up to being discharged from hospital
Intervention Type
Dietary Supplement
Intervention Name(s)
ONS Pre-op + ONS Post-op
Intervention Description
Participants will consume the oral nutrition supplementation (ONS) in addition to normal diet for 14 days pre-operatively and post-operatively up to participants being discharged from the hospital.
Intervention Type
Dietary Supplement
Intervention Name(s)
ONS Pre-op + ONS Post-op + ONS Post-op 3 months
Intervention Description
Participants will consume the oral nutrition supplementation (ONS) in addition to normal diet for 14 days pre-operatively, post-operatively up to participants being discharged from the hospital and an extended oral nutrition supplementation post-operatively up to 3 months.
Intervention Type
Dietary Supplement
Intervention Name(s)
Usual intake Pre-op + ONS Post-op
Intervention Description
Participants will follow a meal plan of 2000 kcal / day using conventional foods for 14 days pre-operatively and consume oral nutrition supplementation (ONS) in addition to normal diet post-operatively up to participants being discharged from the hospital
Primary Outcome Measure Information:
Title
Change in body weight
Description
Anthropometry measurement
Time Frame
Change from baseline body weight at 4 months
Title
Change in body mass index (BMI)
Description
Anthropometry measurement
Time Frame
Change from baseline body mass index (BMI) at 4 months
Title
Change in serum albumin level
Description
Serum albumin is an indicator of protein stores to assess nutritional status
Time Frame
Change from baseline serum albumin level at 4 months
Title
Change in serum pre-albumin level
Description
Serum pre-albumin is an indicator of protein stores to assess nutritional status
Time Frame
Change from baseline serum pre-albumin level at 4 months
Secondary Outcome Measure Information:
Title
Change in handgrip force
Description
Handgrip force is a measure of handgrip strength by dynamometer
Time Frame
Change from baseline handgrip force at 4 months
Title
Change in muscle mass
Description
Muscle mass reported in kilogram is measured by bioelectrical impedance analyser
Time Frame
Change from baseline muscle mass at 4 months
Title
Change in fat mass
Description
Fat mass reported in kilogram is measured by bioelectrical impedance analyser
Time Frame
Change from baseline fat mass at 4 months
Title
Change in serum transferrin level
Description
Serum transferrin is a measure of nutritional status
Time Frame
Change from baseline serum transferrin level at 4 months
Title
Change in hemoglobin level
Description
Serum hemoglobin is a measure of nutritional status
Time Frame
Change from baseline hemoglobin level at 4 months
Title
Change in high sensitivity c-reactive protein (HsCRP) level
Description
High sensitivity c-reactive protein (HsCRP) is a measure of inflammatory status
Time Frame
Change from baseline high sensitivity c-reactive protein (HsCRP) level at 4 months
Title
Change in Interleukin-6 (IL-6)
Description
Interleukin-6 (IL-6) is a measure of inflammatory status
Time Frame
Change from baseline Interleukin-6 (IL-6) at 4 months
Title
Change in salivary cortisol level
Description
Salivary cortisol level is a biological marker of stress reaction
Time Frame
Change from baseline salivary cortisol level at 4 months
Title
Change in energy intake
Description
Energy intake reported in calories is a dietary measure to assess nutritional status
Time Frame
Change from baseline energy intake at 4 months
Title
Change in protein intake
Description
Protein intake reported in gram is a dietary measure to assess nutritional status
Time Frame
Change from baseline protein intake at 4 months
Title
Change in Pittsburgh Sleep Quality Index (PSQI) scores
Description
Pittsburgh Sleep Quality Index (PSQI) scores range from 0-42.Higher scores indicate poorer sleep quality
Time Frame
Change from baseline Pittsburgh Sleep Quality Index (PSQI) scores at 4 months
Title
Presence of post-surgical complications
Description
Post-surgical complications are indicated by presence of wound infection, chest infection and use of antibiotics, responses are either yes or no
Time Frame
Change from baseline post-surgical complications at 3 months
Title
Length of hospital stay
Description
Number of days participants are admitted into the hospital
Time Frame
Up to 5 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female from all ethnicity
25 to 65 years
BMI not less than 18.0 kg/m²
Cancer patients who are confirmed with elective surgery whose co-morbidities are stabilized based on the ASA Physical Status Classification System ASA Class 1 and 2
Fulfil at least two characteristics of AND/ ASPEN Diagnosis of Malnutrition These characteristics are insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, localized or generalized fluid accumulation and diminished functional status as measured by handgrip strength.
Exclusion Criteria:
Patients who require enteral or parenteral feeding
Pregnant or lactating
On chemotherapy or radiotherapy
Total gastrectomy or ileostomy
Metastasized cancer, upper gastrointestinal cancer, terminal diseases, decompensated liver or renal disease, major concurrent metabolic problem such as uncontrolled diabetes, dementia
On regular steroids prescription
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Winnie SS Chee, PhD
Organizational Affiliation
International Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
International Medical University
City
Kuala Lumpur
ZIP/Postal Code
57000
Country
Malaysia
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34732233
Citation
Wong TX, Chen ST, Ong SH, Shyam S, Kandasami P, Chee WSS. Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery. Trials. 2021 Nov 3;22(1):767. doi: 10.1186/s13063-021-05716-5.
Results Reference
derived
Learn more about this trial
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
We'll reach out to this number within 24 hrs